Bora Pharmaceuticals Co., LTD. Statistics

Total Valuation

Bora Pharmaceuticals Co., LTD. has a market cap or net worth of TWD 84.53 billion. The enterprise value is 98.91 billion.

Market Cap	84.53B
Enterprise Value	98.91B

Important Dates

The next estimated earnings date is Friday, March 7, 2025.

Earnings Date	Mar 7, 2025
Ex-Dividend Date	Aug 12, 2024

Share Statistics

Bora Pharmaceuticals Co., LTD. has 103.34 million shares outstanding. The number of shares has increased by 3.82% in one year.

Current Share Class	n/a
Shares Outstanding	103.34M
Shares Change (YoY)	+3.82%
Shares Change (QoQ)	+1.19%
Owned by Insiders (%)	7.76%
Owned by Institutions (%)	11.43%
Float	59.42M

Valuation Ratios

The trailing PE ratio is 22.04 and the forward PE ratio is 17.48.

PE Ratio	22.04
Forward PE	17.48
PS Ratio	4.96
PB Ratio	7.01
P/TBV Ratio	13.97
P/FCF Ratio	42.99
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.53, with an EV/FCF ratio of 50.30.

EV / Earnings	25.36
EV / Sales	5.92
EV / EBITDA	20.53
EV / EBIT	24.80
EV / FCF	50.30

Financial Position

The company has a current ratio of 1.82, with a Debt / Equity ratio of 1.35.

Current Ratio	1.82
Quick Ratio	1.35
Debt / Equity	1.35
Debt / EBITDA	3.89
Debt / FCF	9.53
Interest Coverage	10.04

Financial Efficiency

Return on equity (ROE) is 35.80% and return on invested capital (ROIC) is 10.42%.

Return on Equity (ROE)	35.80%
Return on Assets (ROA)	7.44%
Return on Capital (ROIC)	10.42%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.50
Inventory Turnover	2.34

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.98% in the last 52 weeks. The beta is 0.75, so Bora Pharmaceuticals Co., LTD.'s price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	+15.98%
50-Day Moving Average	776.68
200-Day Moving Average	771.79
Relative Strength Index (RSI)	56.33
Average Volume (20 Days)	1,003,936

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bora Pharmaceuticals Co., LTD. had revenue of TWD 16.71 billion and earned 3.90 billion in profits. Earnings per share was 37.12.

Revenue	16.71B
Gross Profit	7.53B
Operating Income	3.99B
Pretax Income	4.89B
Net Income	3.90B
EBITDA	4.71B
EBIT	3.99B
Earnings Per Share (EPS)	37.12

Full Income Statement

Balance Sheet

The company has 6.48 billion in cash and 18.74 billion in debt, giving a net cash position of -12.26 billion or -118.66 per share.

Cash & Cash Equivalents	6.48B
Total Debt	18.74B
Net Cash	-12.26B
Net Cash Per Share	-118.66
Equity (Book Value)	13.93B
Book Value Per Share	116.69
Working Capital	10.70B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.37 billion and capital expenditures -399.42 million, giving a free cash flow of 1.97 billion.

Operating Cash Flow	2.37B
Capital Expenditures	-399.42M
Free Cash Flow	1.97B
FCF Per Share	19.03

Full Cash Flow Statement

Margins

Gross margin is 45.08%, with operating and profit margins of 23.87% and 23.35%.

Gross Margin	45.08%
Operating Margin	23.87%
Pretax Margin	29.28%
Profit Margin	23.35%
EBITDA Margin	28.22%
EBIT Margin	23.87%
FCF Margin	11.77%

Dividends & Yields

This stock pays an annual dividend of 12.00, which amounts to a dividend yield of 1.52%.

Dividend Per Share	12.00
Dividend Yield	1.52%
Dividend Growth (YoY)	94.84%
Years of Dividend Growth	4
Payout Ratio	31.61%
Buyback Yield	-3.82%
Shareholder Yield	-2.31%
Earnings Yield	4.54%
FCF Yield	2.33%

Dividend Details

Stock Splits

The last stock split was on August 10, 2023. It was a forward split with a ratio of 1.2989035.

Last Split Date	Aug 10, 2023
Split Type	Forward
Split Ratio	1.2989035

Scores

Bora Pharmaceuticals Co., LTD. has an Altman Z-Score of 2.64. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.64
Piotroski F-Score	n/a